首页 | 本学科首页   官方微博 | 高级检索  
     

首荟通便胶囊治疗老年功能性便秘(虚秘证)的疗效观察
引用本文:许晨,刘婷婷,李明森,宇永军,李玉玮. 首荟通便胶囊治疗老年功能性便秘(虚秘证)的疗效观察[J]. 现代药物与临床, 2021, 36(2): 298-301
作者姓名:许晨  刘婷婷  李明森  宇永军  李玉玮
作者单位:天津市人民医院 肛肠外科,天津 300121;天津市人民医院 肛肠外科,天津 300121;天津市人民医院 肛肠外科,天津 300121;天津市人民医院 肛肠外科,天津 300121;天津市人民医院 肛肠外科,天津 300121
基金项目:国家“十三五”重大新药创制专项课题(2019ZX09734001)
摘    要:目的 观察首荟通便胶囊治疗老年功能性便秘(虚秘证)的临床疗效.方法 选择天津市人民医院2017年10月—2020年1月120例老年功能性便秘(虚秘证)患者,根据就诊顺序分为对照组和治疗组,每组各60例.对照组患者服用乳果糖口服液,15 mL/次,2次/d.治疗组患者口服首荟通便胶囊,1粒/次,3次/d.两组均治疗1个月...

关 键 词:首荟通便胶囊  乳果糖口服溶液  老年功能性便秘  Wexner评分
收稿时间:2021-01-07

Clinical observation of Shouhui Tongbian Capsules in treatment of senile functional fonstipation (deficiency syndrome)
XU Chen,LIU Ting-ting,LI Ming-sen,YU Yong-jun,LI Yu-wei. Clinical observation of Shouhui Tongbian Capsules in treatment of senile functional fonstipation (deficiency syndrome)[J]. Drugs & Clinic, 2021, 36(2): 298-301
Authors:XU Chen  LIU Ting-ting  LI Ming-sen  YU Yong-jun  LI Yu-wei
Affiliation:Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, China;Pecking Union Medical College Hospital, Beijing 100730, China;Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China;Institute of Geriatrics, General Hospital of PLA, Beijing 100853, China;Zhongguancun Jiutai Good Clinical Practice Union, Beijing 100027, China;Institute of Hematology, Blood Diseases Hospital, CAMS, Tianjin 300020, China;Beijing Children''s Hospital Affiliated to The Capital Medical University, Beijing 100045, China;CCBR(Beijing) Company Ltd., Beijing 102206, China;The Second Affliated Hospital of Wenzhou Medical University, Wenzhou 325027, China;Jishuitan Hospital, Beijing 100035, China;Baochuang Ruihai(Beijing) Technology Development Co., Ltd., Beijing 100015, China;Beijing Youan Hospital, Capital Medical University, Beijing 100069, China; Chengdu Hehui Pharmaceutical Technology Co., Ltd, Chengdu 611137, China
Abstract:Mainly discusses the drafting background, basis and the applicable scope of Ethical considerations for subject pain management in clinical trials, as well as the main source of pain in clinical trials, the general ethical considerations for subject pain management in clinical trials and ethical considerations for subjects pain caused by some test operation procedures in clinical trials, in order to provide guidance for the pain management of subjects in clinical trials from an ethical perspective. It is applicable to the ethical consideration of subject pain management in the ethical review, as well as the attention of researchers to subject pain management in the development of clinical trial protocol and trial procedure. Paying more attention to subjects'' pain in clinical trials is one of the measures to protect subjects'' rights and interests, which helps to ensure the smooth development of clinical trials.
Keywords:clinical trial  subjects  pain  risks  burden  ethics  standard
本文献已被 维普 万方数据 等数据库收录!
点击此处可从《现代药物与临床》浏览原始摘要信息
点击此处可从《现代药物与临床》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号